7‐Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti‐nociceptive activity in the mouse without increasing blood pressure
Authors:
Open Access
- 1 February 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 108 (2) , 296-297
Abstract
7‐Nitro indazole (7‐NI) inhibits mouse cerebellar nitric oxide synthase (NOS) in vitro with an IC50 of 0.47 μm. Following i.p. administration in mice, 7‐NI (10–50 mg kg−1) produces dose‐related anti‐nociception as evidenced by an inhibition of late phase (15–30 min) but not early phase (0–5 min) hindpaw licking time following subplantar injection of formalin (10 μl, 5% v/v). The ED50 for this effect was 26 mg kg−1 (equivalent to 159.5 μmol kg−1). Similar i.p. administration of 7‐NI (20 and 80 mg kg−1) in urethane‐anaesthetized mice failed to increase MAP. Thus, 7‐NI is a novel inhibitor of NOS which exhibits selectivity for the brain enzyme. Accordingly, 7‐NI may be a useful starting point for the development of selective, centrally acting NOS inhibitors devoid of cardiovascular side effects and as a tool to study the central pharmacological effects of nitric oxide (NO).Keywords
This publication has 6 references indexed in Scilit:
- Synergistic anti‐nociceptive effect ofl‐NG‐nitro arginine methyl ester (l‐NAME) and flurbiprofen in the mouseBritish Journal of Pharmacology, 1992
- Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the ratNeuropharmacology, 1992
- Nitric oxide synthase: Irreversible inhibition by L-N -Nitroarginine in brain andBiochemical and Biophysical Research Communications, 1991
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- l‐NG‐nitro arginine methyl ester exhibits antinociceptive activity in the mouseBritish Journal of Pharmacology, 1991
- Role of endothelium-derived nitric oxide in the regulation of blood pressure.Proceedings of the National Academy of Sciences, 1989